Literature DB >> 15370071

Endothelial function and oxidative stress.

Hisakazu Ogita1, James Liao.   

Abstract

Increased oxidative stress impairs endothelial function and is thought to mediate vascular disease. Several pathological conditions increase the production of reactive oxygen species (ROS) in the vascular wall, including hypercholesterolemia, diabetes, and hypertension. These conditions are associated with endothelial dysfunction and cardiovascular disease. Thus, overall vascular function is dependent upon the balance of oxidant and antioxidant mechanisms, which determines endothelial function. Endothelial function is usually defined as nitric oxide (NO) production and/or bioavailability. Because ROS can interact and inactivate NO, vascular oxidative stress can lead to decrease NO bioavailability. This results in endothelial dysfunction and increased risk of cardiovascular diseases. Several pharmacological approaches have been used to improve endothelial function and decrease oxidative stress. These include treatment modalities that augment the antioxidant defense mechanisms, increase NO production, and inhibit ROS-generating enzymes. This review provides an overview of the relationship between endothelial function and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370071     DOI: 10.1080/10623320490482664

Source DB:  PubMed          Journal:  Endothelium        ISSN: 1026-793X


  29 in total

1.  Endothelial colony-forming cells show a mature transcriptional response to shear stress.

Authors:  Anastasia D Egorova; Marco C DeRuiter; Hetty C de Boer; Simone van de Pas; Adriana C Gittenberger-de Groot; Anton J van Zonneveld; Robert E Poelmann; Beerend P Hierck
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-11-20       Impact factor: 2.416

Review 2.  Ultra-endurance exercise and oxidative damage : implications for cardiovascular health.

Authors:  Wade L Knez; Jeff S Coombes; David G Jenkins
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 3.  Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

Authors:  Rami Khayat; Brian Patt; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-09-20       Impact factor: 4.214

Review 4.  Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy.

Authors:  Rokhsana Mortuza; Subrata Chakrabarti
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 5.  Endothelial dysfunction: its role in hypertensive coronary disease.

Authors:  Islam Bolad; Patrice Delafontaine
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

6.  Exercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension.

Authors:  Deborah L Feairheller; Michael D Brown; Joon-Young Park; Tina E Brinkley; Samar Basu; James M Hagberg; Robert E Ferrell; Nicola M Fenty-Stewart
Journal:  Med Sci Sports Exerc       Date:  2009-07       Impact factor: 5.411

Review 7.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

8.  Hypercholesterolemia and microvascular dysfunction: interventional strategies.

Authors:  Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Robert W Brock; Jefferson C Frisbee
Journal:  J Inflamm (Lond)       Date:  2010-11-18       Impact factor: 4.981

Review 9.  Cellular mechanisms of cardioprotection by calorie restriction: state of the science and future perspectives.

Authors:  Emanuele Marzetti; Stephanie E Wohlgemuth; Stephen D Anton; Roberto Bernabei; Christy S Carter; Christiaan Leeuwenburgh
Journal:  Clin Geriatr Med       Date:  2009-11       Impact factor: 3.076

Review 10.  Oxidative stress impairs endothelial progenitor cell function.

Authors:  Jamie Case; David A Ingram; Laura S Haneline
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.